The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
Persons initiating nPEP should be informed that preexposure prophylaxis (PrEP) can reduce their risk for acquiring HIV in the case of repeat or continuing exposure after the nPEP course. HealthDay ...
Taken as prescribed, PrEP — shorthand for preexposure prophylaxis — is 99% effective in protecting people against sexual ...
The Department of Health and Human Services (HHS) is reportedly poised to slash funding for domestic HIV prevention at the Centers for Disease Control and Prevention (CDC), The Wall Street Journal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback